F01*Dose-Dense Adjuvant Chemotherapy, Treatment-Induced Amenorrhea and Overall Survival in Premenopausal Breast Cancer Patients: A Pooled Analysis of the MIG1 and GIM2 Phase 3 Studies

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdw337.01
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Randomised Trial: Survival Benefit and Safety of Adjuvant Dose-Dense Chemotherapy for Node-Positive Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

A Nomogram to Predict the Overall Survival of Breast Cancer Patients and Guide the Postoperative Adjuvant Chemotherapy in China

Cancer Management and Research
Oncology
2019English

Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Sedentary Work and the Risk of Breast Cancer in Premenopausal and Postmenopausal Women: A Pooled Analysis of Two Case–control Studies

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
2016English

The Prosigna Gene Expression Assay and Responsiveness to Adjuvant Cyclophosphamide-Based Chemotherapy in Premenopausal High-Risk Patients With Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2018English

Relationship Between Reproductive History, Anthropometrics, Lifestyle Factors, and the Likelihood of Persistent Chemotherapy-Related Amenorrhea in Women With Premenopausal Breast Cancer

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2012English

Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment

Clinical Drug Investigation
MedicinePharmacology
2017English

Delivery of Adjuvant Sequential Dose-Dense FEC–Doc to Patients With Breast Cancer Is Feasible, but Dose Reductions and Toxicity Are Dependent on Treatment Sequence

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Tamoxifen — No Longer a Golden Standard for Adjuvant Therapy in the Treatment of Premenopausal Patients With Hormone-Sensitive Breast Cancer

Nowotwory
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy